SVAYX
Price
$25.43
Change
+$0.24 (+0.95%)
Updated
May 8 closing price
Net Assets
1.27B
VIVAX
Price
$65.66
Change
+$0.25 (+0.38%)
Updated
May 8 closing price
Net Assets
183.65B
Ad is loading...

SVAYX vs VIVAX

Header iconSVAYX vs VIVAX Comparison
Open Charts SVAYX vs VIVAXBanner chart's image
SEI Large Cap Value Y (SIMT)
Price$25.43
Change+$0.24 (+0.95%)
VolumeN/A
Net Assets1.27B
Vanguard Value Index I
Price$65.66
Change+$0.25 (+0.38%)
VolumeN/A
Net Assets183.65B
SVAYX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SVAYX vs. VIVAX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SVAYX is a StrongBuy and VIVAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 184B vs. SVAYX (1.27B). VIVAX (2.22) and SVAYX (2.20) have matching dividends . SVAYX was incepted earlier than VIVAX: SVAYX (10 years) vs VIVAX (33 years). SVAYX (0.68) is less costly to investors than VIVAX (0.17). SVAYX is a more actively managed with annual turnover of: 15.00 vs. VIVAX (9.00). VIVAX has a lower initial minimum investment than SVAYX: VIVAX (3000) vs SVAYX (100000). VIVAX annual gain was more profitable for investors over the last year : 5.12 vs. SVAYX (-1.53). VIVAX return over 5 years is better than : 72.17 vs. SVAYX (51.25).
SVAYXVIVAXSVAYX / VIVAX
Total Expense Ratio0.680.17400%
Annual Report Gross Expense Ratio0.680.17400%
Fund Existence10 years33 years-
Gain YTD-0.309-0.95832%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets1.27B184B1%
Annual Yield % from dividends2.202.2299%
Returns for 1 year-1.535.12-30%
Returns for 3 years2.5120.6612%
Returns for 5 years51.2572.1771%
Returns for 10 yearsN/A96.24-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MOS32.250.69
+2.19%
Mosaic Company (The)
TNDM22.740.48
+2.16%
Tandem Diabetes Care
LGO1.440.02
+1.41%
Largo
SCNI2.80N/A
N/A
Scinai Immunotherapeutics Ltd.
TXO17.00N/A
N/A
TXO Partners LP